Position in AZN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$967,820
New position
Shares Held
5,104
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#680
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COURIER CAPITAL LLC holds $42,194,870 across 11 Drug Manufacturers - General names. AZN ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
64,486 | $16,377,509 | |
| 2 | MRK |
Merck & Co., Inc.
|
53,603 | $6,887,985 | |
| 3 | LLY |
ELI LILLY & Co
|
4,669 | $5,600,139 | |
| 4 | AMGN |
Amgen Inc
|
12,257 | $4,438,504 | |
| 5 | ABBV |
AbbVie Inc.
|
15,875 | $3,994,785 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,523 | $2,046,835 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
5,104 | $967,820 | |
| 8 | PFE |
Pfizer Inc
|
39,040 | $940,083 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $967,820 | 5,104 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||